Aurobindo Pharma Limited, a biopharmaceutical company, engages in the manufacture of generic formulations and active pharmaceutical ingredients in India, the United States of America, Europe, Puerto Rico, and internationally. The company offers formulation in form of oral solids, liquids, injectables, and vaccines, as well as over-the-counter drugs; and active pharmaceutical ingredients (APIs), biosimilars, biocatalysts, peptides, and hormones targeting key therapeutic areas, including central nervous system, cardiovascular, respiratory, antibiotics, anti-retroviral, anti-diabetics, gastroenterology, oncology, and dermatology. It also provides antiretroviral drugs for the people and children living with HIV; and provides project-based chemistry contract services that cover the clinical stage through to manufacturing and management of the entire drug lifecycle in the API space for sterile and non-sterile penicillin’s, cephalosporins, penems, and non-beta lactams. The company was incorporated in 1986 and is headquartered in Hyderabad, India.
तुलना करने के लिए मीट्रिक्स | ARBN | पीअर्स समकक्ष - बारीकी से मेल खाने वाली कंपनियों से संबंधित मेट्रिक्स का औसत ARBN: CIPLA, HIKAL, LUPIN, LAURUSLABS, IPCALAB | क्षेत्र सेक्टर - संबंधित क्षेत्र की कंपनियों के व्यापक समूह से मेट्रिक्स का औसत हेल्थकेयर | संबंध संबंधARBNपीअर्सक्षेत्र |
---|---|---|---|---|
पी/ई अनुपात | 22.3x | 39.6x | −0.6x | |
PEG अनुपात | 0.29 | 0.97 | 0.00 | |
क़ीमत/बुक | 2.6x | 4.9x | 2.6x | |
क़ीमत / एलटीएम बिक्री | 2.6x | 4.6x | 3.2x | |
अपसाइड (विश्लेषक लक्ष्य) | 20.2% | 5.1% | 44.2% | |
उचित मूल्य अपसाइड | अनलॉक करें | −17.4% | 6.1% | अनलॉक करें |